Investing.com - Thermo Fisher Scientific reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $2.94 on revenue of $6.27B. Analysts polled by Investing.com expected EPS of $2.87 on revenue of $6.18B. That compared to EPS of $2.62 on revenue of $5.92B in the same period a year earlier. The company had reported EPS of $3.04 on revenue of $6.32B in the previous quarter.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Novartis ADR earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. Investing.com analysts expected EPS of $1.33 on revenue of $11.71B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar